Loading…
Ardelyx, Inc. is projected to rise to $6.32 by 2027, a +20% move from its current price of $5.28. ARDX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $5.15 | $5.28 | $5.41 | +0.03% |
| Jul 15 | $5.10 | $5.28 | $5.47 | +0.06% |
| Jul 16 | $5.06 | $5.28 | $5.52 | +0.08% |
| Jul 17 | $5.03 | $5.29 | $5.55 | +0.11% |
| Jul 18 | $5.00 | $5.29 | $5.59 | +0.14% |
| Jul 19 | $4.98 | $5.29 | $5.62 | +0.17% |
| Jul 20 | $4.95 | $5.29 | $5.65 | +0.20% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.95 | $5.29 | $5.65 | +0.20% |
| Week 2 | $4.83 | $5.30 | $5.82 | +0.39% |
| Week 3 | $4.74 | $5.31 | $5.95 | +0.59% |
| Week 4 | $4.67 | $5.32 | $6.07 | +0.79% |
| Week 5 | $4.60 | $5.33 | $6.17 | +0.98% |
| Week 6 | $4.55 | $5.34 | $6.27 | +1.18% |
| Week 7 | $4.50 | $5.35 | $6.37 | +1.38% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ardelyx, Inc. is a healthcare company that discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis.
Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Ardelyx, Inc. (ARDX) trades at $5.10 and has a market capitalization of $1.26B. The company is ranked 2390 by market position.
Forecasts place 2026 at an average of $5.10 with a range from $5.10 to $6.86 and a neutral sentiment. The projection shows bullish momentum beginning in 2027, with 2027 average $6.19 and max $8.33 (ROI 21.4%), 2028 average $6.33 and max $8.85 (ROI 24.1%), 2029 average $6.45 and max $9.31 (ROI 26.4%), and 2030 average $7.08 with max $10.48 (ROI 38.8%). By 2040 the average is projected to $16.39 (ROI 221.4%), and by 2050 the average is $28.40 (ROI 456.9%).
A major floor 18.3% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 20.6% above — a clean break opens room to run.
A major ceiling 38.3% above — clearing it would confirm fresh momentum.
Key ARDX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ARDX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.36 | Sell | $5.35 | Sell |
| MA 10 | $5.31 | Sell | $5.42 | Sell |
| MA 20 | $5.63 | Sell | $5.55 | Sell |
| MA 50 | $5.99 | Sell | $5.81 | Sell |
| MA 100 | $6.02 | Sell | $5.97 | Sell |
| MA 200 | $6.05 | Sell | $5.94 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.26 | Neutral |
| Stoch RSI (14) | 21.93 | Neutral |
| CCI (20) | -73.33 | Neutral |
| Williams %R (14) | -85.83 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -14.56 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 14.17 | Buy |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -0.35 | Sell |
| Ultimate (7,14,28) | 53.97 | Neutral |
| Momentum (10) | -0.78 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 5.41 | Sell |
| ADX (14) | 19.11 | Neutral |
| ATR (14) | 0.13 | Info |
The 30-day technical picture points to bearish conditions for ARDX. RSI14 is 30.
SMA50 and SMA200 are both $6.09, indicating near-term resistance above the current price.
Support is at $5.10 and resistance at $6.37, with a 30-day price range of $4.19 to $6.20. Annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.10 | $5.28 | $7.02 | 0% | Neutral | |
| $5.08 | $6.32 | $8.30 | +20% | Neutral | |
| $5.16 | $6.59 | $8.95 | +25% | Bullish | |
| $5.27 | $6.87 | $9.58 | +30% | Bullish | |
| $5.58 | $7.41 | $10.58 | +40% | Bullish | |
| $5.92 | $7.99 | $11.63 | +51% | Bullish | |
| $7.00 | $9.60 | $14.22 | +82% | Bullish | |
| $7.70 | $10.72 | $16.13 | +103% | Bullish | |
| $7.90 | $11.14 | $17.01 | +111% | Bullish | |
| $7.94 | $11.35 | $17.57 | +115% | Bullish | |
| $11.45 | $17.36 | $28.48 | +229% | Bullish | |
| $18.29 | $30.65 | $54.70 | +481% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $5.10 | $5.28 | $6.41 | +0.00% |
| August 2026 | $4.61 | $5.43 | $6.55 | +2.77% |
| September 2026 | $4.57 | $5.42 | $6.60 | -0.19% |
| October 2026 | $4.70 | $5.60 | $6.88 | +3.32% |
| November 2026 | $4.78 | $5.72 | $7.09 | +2.28% |
| December 2026 | $4.69 | $5.63 | $7.02 | -1.62% |
Click any year to see its month-by-month ARDX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ARDX is projected to trade between $5.10 and $7.02, averaging $5.28 — a potential gain of 0% from today's $5.28. Price action looks broadly range-bound.
Ardelyx, Inc.'s 2027 outlook centres on $6.32, within a $5.08 to $8.30 range. That is up +20% on the projected 2026 average. That marks a +20% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, ARDX could reach as high as $8.95, with a base case around $6.59 and support toward $5.16 — roughly +25% from $5.28. Momentum favours further upside here.
Expect ARDX to range from $5.27 to $9.58 through 2029. The $6.87 average target implies a +30% move from current prices. That is up +4% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The ARDX price prediction for 2030 points to an average of $7.41 (low $5.58, high $10.58) — a potential gain of +40% on today's $5.28. Momentum favours further upside here.
In 2031, ARDX is projected to trade between $5.92 and $11.63, averaging $7.99 — a potential gain of +51% from today's $5.28. That is up +8% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Ardelyx, Inc.'s 2032 outlook centres on $9.60, within a $7.00 to $14.22 range. That is up +20% on the projected 2031 average. That marks a +82% change versus current levels. Momentum favours further upside here.
By 2033, ARDX could reach as high as $16.13, with a base case around $10.72 and support toward $7.70 — roughly +103% from $5.28. Buyers look set to stay in control over this stretch.
Expect ARDX to range from $7.90 to $17.01 through 2034. The $11.14 average target implies a +111% move from current prices. That is up +4% on the projected 2033 average. Momentum favours further upside here.
The ARDX price prediction for 2035 points to an average of $11.35 (low $7.94, high $17.57) — a potential gain of +115% on today's $5.28. Buyers look set to stay in control over this stretch.
In 2040, ARDX is projected to trade between $11.45 and $28.48, averaging $17.36 — a potential gain of +229% from today's $5.28. That is up +53% on the projected 2035 average. Momentum favours further upside here.
Ardelyx, Inc.'s 2050 outlook centres on $30.65, within a $18.29 to $54.70 range. That is up +77% on the projected 2040 average. That marks a +481% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ARDX today (≈ 189.393939 ARDX) could be worth
$5,804.98
+$4,804.98 (+480%) by 2050 · US Dollar
Based on the average projected ARDX price of $30.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ARDXwould be worth at today's price.
$1,000 invested in ARDX on Jul 10, 2025 (≈ 212.765966 ARDX) would be worth
$1,123.4
+$123.4 (+12.3%) today · 1.12× · US Dollar
Based on a ARDX entry price of $4.7 vs. today's $5.28.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.27 | $1,001.9 | +0.2% |
| 1 month ago | $5.61 | $941.18 | -5.9% |
| 3 months ago | $6.18 | $854.37 | -14.6% |
| 6 months ago | $7.36 | $717.39 | -28.3% |
| 1 year ago | $4.7 | $1,123.4 | +12.3% |
| All time (5.0y) ago | $7.73 | $683.05 | -31.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ARDX forecast.
Our base-case forecast reaches $11.00 around 2034.
Implied market cap at $11.00: $2.72B
The multi-year forecast shows a bullish trajectory starting in 2027 and continuing through 2050. The 2027 average is $6.19 (max $8.33) with ROI 21.4% and bullish sentiment; 2028 average $6.33 (max $8.85) with ROI 24.1%; 2029 average $6.45 (max $9.31) with ROI 26.4%; 2030 average $7.08 (max $10.48) with ROI 38.8%. In 2031 the average is $7.47 (max $11.32) ROI 46.5%; 2032 average $9.14 (max $14.13) ROI 79.3%; 2033 average $10.48 (max $16.50) ROI 105.5%; 2034 average $10.50 (max $16.81) ROI 106%; 2035 average $10.55 (max $17.15) ROI 106.9%.
By 2040 the average is projected to $16.39 (max $28.45) ROI 221.4%, and by 2050 the average is $28.40 (max $54.20) ROI 456.9%. The outlook remains bullish across the long horizon, though these are estimates and not guarantees, with higher volatility reflected in the forecast.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $7.08, a max of $10.48, and a ROI of 38.8%.
Forecasts indicate neutral to bullish momentum starting in 2027, with 2030 average of $7.08 and ROI of 38.8%, rising to $28.40 average by 2050 with ROI of 456.9%. Note that 2026 is neutral, and these are estimates, not guarantees.
Yes. The 2030 max forecast is $10.48, suggesting a possibility of hitting $10 in 2030 under the max scenario.
Current price is $5.10 and market cap is $1.26B.
The 30-day picture is bearish with RSI14 at 30. SMA50 and SMA200 are both $6.09. Support is at $5.10 and resistance at $6.37, with a 30-day range of $4.19 to $6.20 and annualized volatility of 60%.
Ardelyx, Inc. Community Discussion
0Share your Ardelyx, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.